TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.

Denis M Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.